Ananda Health announced today that it has acquired Elixinol’s U.S. operations and is expanding its contract manufacturing and third‑party logistics services to capture growth as federal hemp rules change on December 11, 2026.
Ananda Health Expands Manufacturing and 3PL Platform
With the Elixinol acquisition now complete, Ananda Health is scaling its vertically integrated platform to serve both existing brands and new entrants across the dietary supplement and wellness markets.
Elixinol will continue as a standalone brand under the Ananda Health umbrella, preserving its customer base and product lines without disruption.
Regulatory Shift Looms on December 11, 2026
Federal hemp law revisions set to take effect on December 11, 2026 will apply a total‑THC standard and exclude certain high‑THC cannabinoid products, threatening roughly 95% of current hemp offerings.
Ananda Health says its established manufacturing infrastructure, distribution network and compliance expertise give it a competitive edge in the reshaped market.
Facility and Services
Based in Georgetown, Kentucky, Ananda Health operates the only LEED Platinum‑certified dietary supplement facility in the United States, housing cGMP manufacturing, formulation, R&D, quality testing, and full pick‑pack‑ship capabilities.
The expanded contract manufacturing service covers white label, private label and toll manufacturing for tinctures, topicals, molten/hot‑fill products, gummies, and soon powders and capsules.
Strategic Outlook for the Hemp Market
According to President Alex Nance, the acquisition creates immediate continuity for Elixinol customers while unlocking growth through Ananda’s manufacturing scale and 3PL capacity.
Nance emphasized that consumer demand for natural pain, sleep and stress solutions remains strong, and the company will streamline the transition for pharmacies, partners and manufacturing clients.
Market Position
Ananda Health currently serves more than 2,000 independent pharmacies nationwide and plans to keep this channel central as non‑compliant products exit the market.
The company’s brand portfolio includes Ananda Professional and Elixinol, with products available online and through pharmacy partners.
